News

Since the first SGLT2 inhibitor drug was approved in 2013, the medications have gone from targeting glucose-lowering to also providing cardiac protection and heart benefits.

A new study co-led by a Saint Luke's researcher found that EMS practices for out-of-hospital cardiac arrest (OHCA) are different in predominantly Black/Hispanic areas compared to mostly white areas.

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

A study led by Saint Luke’s Mid America Heart Institute researchers found drastic improvements following the American Heart Association’s IMPLEMENT-HF Initiative.

Melissa Magwire, RN, MSN, CDE, discusses the interrelated conditions of diabetes and cardiometabolic disease and how the Cardiometabolic Center of Excellence is changing the game for treatment.

Anthony Weatherspoon, who received lifesaving heart and kidney transplants, is grateful for the gift of life this April.

Learn how the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence is making a difference in the lives of diabetes patients.

Dr. James O'Keefe shares insights on how exercise and social activities can boost physical and mental health and help you live longer.

Chandler DeBolt needed immediate attention but had extremely limited options before his family was referred to the Adult Congenital Heart Disease program at Saint Luke’s Mid America Heart Institute in Kansas City.